Clinical Trial: Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients

Study Status: COMPLETED
Recruit Status: COMPLETED
Study Type: OBSERVATIONAL



Official Title: Economic Burden Associated With Nintedanib Non-adherence Among Medicare Beneficiaries With IPF

Brief Summary:

This study has two objectives:

  1. To assess the association between nintedanib adherence trajectory group (as measured from a Group-based Trajectory Modelling (GBTM)) and health care resource use, with a focus on inpatient hospitalization, among patients with Idiopathic Pulmonary Fibrosis (IPF).
  2. To assess the association between a patient's nintedanib adherence trajectory group (as measured from a GBTM) and their medical costs among patients with IPF.